BioNTech veröffentlicht Ergebnisse des zweiten Quartals 2021 und Informationen zur Geschäftsentwicklung
09 août 2021 07h00 HE
|
BioNTech SE
Auslieferung von weltweit mehr als einer Milliarde BNT162b2-Impfstoffdosen in über 100 Länder oder Regionen bis zum 21. Juli 2021 Geschlossene Lieferverträge für 2021 umfassen rund 2,2 Milliarden...
BioNTech veröffentlicht am 9. August 2021 Ergebnisse des zweiten Quartals sowie Informationen zum operativen Fortschritt
02 août 2021 07h00 HE
|
BioNTech SE
MAINZ, Deutschland, 2. August 2021 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, „BioNTech” oder „das Unternehmen“) wird am Montag, den 9. August 2021, die Ergebnisse des zweiten Quartals 2021...
BioNTech to Report Second Quarter Financial Results and Operational Update on August 9, 2021
02 août 2021 07h00 HE
|
BioNTech SE
Mainz, Germany, August 2, 2021 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the second quarter on Monday, August 9th, 2021....
Entera Bio To Present At The H.C. Wainwright Global Life Sciences Conference
04 mars 2021 08h30 HE
|
Entera Bio Ltd.
BOSTON and JERUSALEM, March 04, 2021 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of orally delivered large molecule therapeutics, announced that members of its...
Cognition Therapeutics to Present Corporate and Clinical Update at H.C. Wainwright Global Life Sciences Conference
03 mars 2021 08h01 HE
|
Cognition Therapeutics, Inc.
New York, NY, March 03, 2021 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., a clinical stage neuroscience company developing drugs that treat neurodegenerative disorders by regulating cellular...
vTv Therapeutics to Participate in the LifeSci Partners 10th Annual Healthcare Corporate Access Event Virtually
06 janv. 2021 16h30 HE
|
vTv Therapeutics Inc.
HIGH POINT, N.C., Jan. 06, 2021 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT) a clinical-stage biopharmaceutical company focused on the development of orally administered treatments for...
BioNTech präsentiert auf der 39. Annual J.P. Morgan Healthcare Conference
05 janv. 2021 06h00 HE
|
BioNTech SE
MAINZ, Deutschland, 5. Januar 2021 (GLOBE NEWSWIRE) — BioNTech SE (Nasdaq: BNTX, „BioNTech” oder „das Unternehmen”) gab heute bekannt, dass CEO und Mitgründer Prof. Dr. Ugur Sahin das Unternehmen...
BioNTech to Present at the 39th Annual J.P. Morgan Healthcare Conference
05 janv. 2021 06h00 HE
|
BioNTech SE
MAINZ, GERMANY, January 5, 2021 (GLOBE NEWSWIRE) — BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced today that CEO and Co-founder Ugur Sahin, M.D., will present a corporate overview...
Entera Bio to Present at the H.C. Wainwright 6th Annual Israel Conference
02 nov. 2020 16h05 HE
|
Entera Bio Ltd.
BOSTON and JERUSALEM, Nov. 02, 2020 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of orally delivered large molecule therapeutics, announced that members of its...
Adevinta ASA (ADE) - Adevinta reports further recovery in Q3
27 oct. 2020 02h01 HE
|
Adevinta ASA
Agreement to acquire eBay Classifieds Group Improving trends confirmed EBITDA margin exceptionally high, driven by cost saving initiatives, delayed expenses and positive one-offs Significant...